v3.26.3
Assets Held for Sale and Divestiture (Tables)
3 Months Ended
Aug. 31, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Major Classes of Assets and Liabilities Held for Sale

The major classes of assets and liabilities held for sale of the Genomics business were as follows:

 

 

August 31, 2026

 

 

May 31, 2026

 

Accounts receivable, net

$

4.0

 

 

$

3.8

 

Inventory, net

 

12.4

 

 

 

10.3

 

Prepaid expenses and other current assets

 

1.7

 

 

 

1.5

 

Property and equipment, net

 

20.1

 

 

 

20.1

 

Right of use assets

 

0.9

 

 

 

0.9

 

Goodwill

 

19.4

 

 

 

19.4

 

Amortizable intangible assets, net

 

7.9

 

 

 

7.9

 

Other non-current assets

 

4.0

 

 

 

4.1

 

Total assets held for sale

$

70.4

 

 

$

68.0

 

 

 

 

 

 

 

Accounts payable

$

1.6

 

 

$

0.9

 

Accrued compensation

 

2.5

 

 

 

2.0

 

Other liabilities

 

3.2

 

 

 

3.7

 

Total liabilities held for sale

$

7.3

 

 

$

6.6